Whady Hueb

Summary

Country: Brazil

Publications

  1. ncbi Mild chronic kidney dysfunction and treatment strategies for stable coronary artery disease
    Neuza Helena Lopes
    Heart Institute, University of Sao Paulo Medical School, Sao Paulo, Brazil
    J Thorac Cardiovasc Surg 137:1443-9. 2009
  2. ncbi Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnet
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    BMC Cardiovasc Disord 12:65. 2012
  3. ncbi Five-year follow-up of angiographic disease progression after medicine, angioplasty, or surgery
    Jorge Chiquie Borges
    Heart Institute InCor, University of São Paulo Medical of School, Sao Paulo, Brazil
    J Cardiothorac Surg 5:91. 2010
  4. ncbi Five-year follow-up of a randomized comparison between off-pump and on-pump stable multivessel coronary artery bypass grafting. The MASS III Trial
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    Circulation 122:S48-52. 2010
  5. ncbi Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    Circulation 122:949-57. 2010
  6. ncbi Hypotheses, rationale, design, and methods for prognostic evaluation in type 2 diabetic patients with angiographically normal coronary arteries. The MASS IV-DM Trial
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    BMC Cardiovasc Disord 10:47. 2010
  7. ncbi Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    Circulation 115:1082-9. 2007
  8. ncbi Impact of diabetes on five-year outcomes of patients with multivessel coronary artery disease
    Whady Hueb
    Heart Institute, University of Sao Paulo, Sao Paulo, Brazil
    Ann Thorac Surg 83:93-9. 2007
  9. ncbi The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    J Am Coll Cardiol 43:1743-51. 2004
  10. ncbi Effect of complete revascularization on 10-year survival of patients with stable multivessel coronary artery disease: MASS II trial
    Ricardo D Oliveira Vieira
    Department of Atherosclerosis, Heart Institute of University of São Paulo, Sao Paulo, Brazil
    Circulation 126:S158-63. 2012

Collaborators

Detail Information

Publications29

  1. ncbi Mild chronic kidney dysfunction and treatment strategies for stable coronary artery disease
    Neuza Helena Lopes
    Heart Institute, University of Sao Paulo Medical School, Sao Paulo, Brazil
    J Thorac Cardiovasc Surg 137:1443-9. 2009
    ....
  2. ncbi Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnet
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    BMC Cardiovasc Disord 12:65. 2012
    ....
  3. ncbi Five-year follow-up of angiographic disease progression after medicine, angioplasty, or surgery
    Jorge Chiquie Borges
    Heart Institute InCor, University of São Paulo Medical of School, Sao Paulo, Brazil
    J Cardiothorac Surg 5:91. 2010
    ..This study compared progression of coronary artery disease in native coronary arteries in patients undergoing surgery, angioplasty, or medical treatment...
  4. ncbi Five-year follow-up of a randomized comparison between off-pump and on-pump stable multivessel coronary artery bypass grafting. The MASS III Trial
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    Circulation 122:S48-52. 2010
    ..Few data are available on the effects of off-pump coronary artery bypass graft surgery (OPCAB) on cardiac events and long-term clinical outcomes...
  5. ncbi Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    Circulation 122:949-57. 2010
    ....
  6. ncbi Hypotheses, rationale, design, and methods for prognostic evaluation in type 2 diabetic patients with angiographically normal coronary arteries. The MASS IV-DM Trial
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    BMC Cardiovasc Disord 10:47. 2010
    ..The MASS IV-DM Trial is a large project from a single institution, the Heart Institute (InCor), University of São Paulo Medical School, Brazil to study ventricular function and coronary arteries in patients with type 2 diabetes mellitus...
  7. ncbi Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    Circulation 115:1082-9. 2007
    ....
  8. ncbi Impact of diabetes on five-year outcomes of patients with multivessel coronary artery disease
    Whady Hueb
    Heart Institute, University of Sao Paulo, Sao Paulo, Brazil
    Ann Thorac Surg 83:93-9. 2007
    ....
  9. ncbi The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    J Am Coll Cardiol 43:1743-51. 2004
    ..We sought to evaluate the relative efficacies of three possible therapeutic strategies for patients with multivessel coronary artery disease (CAD), stable angina, and preserved ventricular function...
  10. ncbi Effect of complete revascularization on 10-year survival of patients with stable multivessel coronary artery disease: MASS II trial
    Ricardo D Oliveira Vieira
    Department of Atherosclerosis, Heart Institute of University of São Paulo, Sao Paulo, Brazil
    Circulation 126:S158-63. 2012
    ....
  11. ncbi Clinical judgment and treatment options in stable multivessel coronary artery disease: results from the one-year follow-up of the MASS II (Medicine, Angioplasty, or Surgery Study II)
    Alexandre C Pereira
    Heart Institute InCor, University of Sao Paulo Medical School, Sao Paulo, Brazil
    J Am Coll Cardiol 48:948-53. 2006
    ....
  12. ncbi Cost-effectiveness analysis for surgical, angioplasty, or medical therapeutics for coronary artery disease: 5-year follow-up of medicine, angioplasty, or surgery study (MASS) II trial
    Ricardo D Oliveira Vieira
    Department of Atherosclerosis, Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    Circulation 126:S145-50. 2012
    ..This investigation compares the economic outcome at 5-year follow-up of the 3 therapeutic strategies...
  13. ncbi Effect of a hypoglycemic agent on ischemic preconditioning in patients with type 2 diabetes and stable angina pectoris
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    Coron Artery Dis 18:55-9. 2007
    ....
  14. ncbi Cancer-related deaths among different treatment options in chronic coronary artery disease: results of a 6-year follow-up of the MASS II study
    Ricardo D Vieira
    Heart Institute InCor of the University of Sao Paulo, Sao Paulo, Brazil
    Coron Artery Dis 23:79-84. 2012
    ..Noncardiac causes of death may distort the interpretation of the long-term effects of coronary revascularization...
  15. ncbi Dynamic regulation of MTHFR mRNA expression and C677T genotype modulate mortality in coronary artery disease patients after revascularization
    Alexandre C Pereira
    Heart Institute, University of Sao Paulo Medical School, Sao Paulo, Brazil
    Thromb Res 121:25-32. 2007
    ..Here, we investigate whether MTHFR gene variants are associated with an increased cardiovascular risk in individuals submitted to CABG. We also propose a molecular mechanism to explain our findings...
  16. ncbi Impact of metabolic syndrome on the outcome of patients with stable coronary artery disease: 2-year follow-up of the MASS II study
    Neuza H Lopes
    Heart Institute InCor of the University of Sao Paulo, Sao Paulo, Brazil
    Coron Artery Dis 19:383-8. 2008
    ..We characterized the impact of the metabolic syndrome (MetS) and its components on cardiovascular adverse events in patients with symptomatic chronic multivessel coronary artery disease, which have been followed prospectively for 2 years...
  17. ncbi Effect of glycoprotein IIIa PlA2 polymorphism on outcome of patients with stable coronary artery disease and effect of smoking
    Neuza H M Lopes
    Heart Institute InCor of the University of Sao Paulo, Sao Paulo, Brazil
    Am J Cardiol 93:1469-72. 2004
    ..Smokers with the Pl(A2) polymorphism of platelet glycoprotein IIIa are at greater risk for subsequent cardiac events in stable coronary disease...
  18. ncbi Hemostatic changes and clinical sequelae after on-pump compared with off-pump coronary artery bypass surgery: a prospective randomized study
    Felipe S Paulitsch
    Heart Institute, University of Sao Paulo, Sao Paulo, Brazil
    Coron Artery Dis 20:100-5. 2009
    ..To delineate the effects of extracorporeal bypass on biomarkers of hemostasis, fibrinolysis, and inflammation and clinical sequelae...
  19. ncbi Quality of life in patients with symptomatic multivessel coronary artery disease: a comparative post hoc analyses of medical, angioplasty or surgical strategies-MASS II trial
    Maria Elenita Favarato
    Heart Institute InCor, University of Sao Paulo School of Medicine, Sao Paulo, SP, Brazil
    Int J Cardiol 116:364-70. 2007
    ..We evaluated the impact of Coronary Artery Bypass Graft Surgery (CABG), Percutaneous Coronary Intervention (PCI) or Medical Therapy (MT) on self-perceived quality of life among patients with stable Coronary Artery Disease (CAD)...
  20. ncbi Quality of life after surgical myocardial revascularization, angioplasty or medical treatment
    Myrthes Emy Takiuti
    Instituto do Coracao, Hospital das Clinicas, FM, USP, Sao Paulo, SP, Brazil
    Arq Bras Cardiol 88:537-44. 2007
    ..Although the clinical benefits of coronary interventions seem to be confirmed, their effects on quality of life (QoL) are still scarcely studied...
  21. ncbi The effects of glibenclamide, a K(ATP) channel blocker, on the warm-up phenomenon
    Beatriz M A Ferreira
    Heart Institute of the University of Sao Paulo, Brazil
    Ann Noninvasive Electrocardiol 10:356-62. 2005
    ..This study aimed to investigate the effects of chronic treatment with glibenclamide during two sequential exercise tests...
  22. ncbi Teratoma of the mediastinum: a case report
    Ricardo D Vieira
    Department of Atherosclerosis, Heart Institute of the University of Sao Paulo, Av Dr Eneas de Carvalho Aguiar 44, AB, Sala 114, Cerqueira Cesar, Sao Paulo SP, 05403 000, Brazil
    J Med Case Reports 5:193. 2011
    ..abstract:..
  23. ncbi Effects of epinephrine in local dental anesthesia in patients with coronary artery disease
    Ricardo Simões Neves
    Instituto do Coracao, Hospital das Clinicas, FM, USPSão Paulo, SP, Brazil
    Arq Bras Cardiol 88:545-51. 2007
    ..The use of vasoconstrictors for local anesthesia in patients with coronary heart disease is controversial in the literature, and there is concern regarding risk of cardiac decompensation...
  24. ncbi Relative cost comparison of treatments for coronary artery disease: the First Year Follow-Up of MASS II Study
    Desiderio Favarato
    Heart Institute InCor, University of Sao Paulo School of Medicine, Sao Paulo SP, Brazil
    Circulation 108:II21-3. 2003
    ..The MASS II trial provides an opportunity to compare the costs of CABG and PTCA in addition to a strategy of medical therapy...
  25. ncbi Acute pleuropulmonary complications detected by computed tomography following myocardial revascularization
    Francisco S Vargas
    Heart Institute, , Faculty of Medicine, , Brazil
    Rev Hosp Clin Fac Med Sao Paulo 57:135-42. 2002
    ..Factors that contribute to the persistence of changes on the left side include the thoracic trauma and the presence of chest tubes and pericardial effusion...
  26. ncbi LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease
    Andrei C Sposito
    Heart Institute (InCor, University of Sao Paulo Medical School, Sao Paulo, Brazil
    Atherosclerosis 161:447-53. 2002
    ..Concluding, in patients with CAD, LDL catabolic pathway significantly influences the removal from plasma of chylomicron remnants...
  27. ncbi Plasma kinetics of a cholesterol-rich emulsion in subjects with or without coronary artery disease
    Raul D Santos
    Lipid Metabolism Laboratory, The Heart Institute (InCor, Medical School Hospital (InCor-HCFMUSP, , , Brazil
    J Lipid Res 44:464-9. 2003
    ..In conclusion, both removal from the plasma and esterification of the LDE-cholesterol were increased in CAD. These findings may contribute for unraveling pro-atherogenic mechanisms and the establishment of novel CAD markers...
  28. ncbi Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment: a long-term follow-up study
    Andrei C Sposito
    Heart Institute (InCor, Zerbini Foundation, Brasilia, Brazil
    J Am Coll Cardiol 43:2225-32. 2004
    ..21 to 9.14; p = 0.020). CONCLUSIONS: The current study establishes that delayed intravascular TG lipolysis is a strong and independent predictor of evolution to severe angina among patients undergoing secondary prevention therapy of CAD...